Dearborn Partners’s IGC Pharma IGC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8K | Hold |
84,401
| – | – | ﹤0.01% | 256 |
|
|
2025
Q1 | $24.1K | Sell |
84,401
-25,000
| -23% | -$7.13K | ﹤0.01% | 257 |
|
|
2024
Q4 | $36.8K | Sell |
109,401
-7,000
| -6% | -$2.35K | ﹤0.01% | 259 |
|
|
2024
Q3 | $49.7K | Hold |
116,401
| – | – | ﹤0.01% | 266 |
|
|
2024
Q2 | $50.5K | Sell |
116,401
-309
| -0.3% | -$134 | ﹤0.01% | 255 |
|
|
2024
Q1 | $46.7K | Hold |
116,710
| – | – | ﹤0.01% | 259 |
|
|
2023
Q4 | $32.7K | Hold |
116,710
| – | – | ﹤0.01% | 255 |
|
|
2023
Q3 | $41.9K | Hold |
116,710
| – | – | ﹤0.01% | 235 |
|
|
2023
Q2 | $36.4K | Hold |
116,710
| – | – | ﹤0.01% | 235 |
|
|
2023
Q1 | $39.6K | Sell |
116,710
-17,691
| -13% | -$6.01K | ﹤0.01% | 239 |
|
|
2022
Q4 | $42.8K | Hold |
134,401
| – | – | ﹤0.01% | 243 |
|
|
2022
Q3 | $58K | Buy |
134,401
+9,375
| +7% | +$4.05K | ﹤0.01% | 254 |
|
|
2022
Q2 | $66K | Buy |
125,026
+28,125
| +29% | +$14.8K | ﹤0.01% | 253 |
|
|
2022
Q1 | $92K | Hold |
96,901
| – | – | ﹤0.01% | 272 |
|
|
2021
Q4 | $95K | Hold |
96,901
| – | – | ﹤0.01% | 269 |
|
|
2021
Q3 | $143K | Hold |
96,901
| – | – | 0.01% | 250 |
|
|
2021
Q2 | $159K | Hold |
96,901
| – | – | 0.01% | 249 |
|
|
2021
Q1 | $173K | Hold |
96,901
| – | – | 0.01% | 246 |
|
|
2020
Q4 | $151K | Hold |
96,901
| – | – | 0.01% | 250 |
|
|
2020
Q3 | $101K | Sell |
96,901
-5,859
| -6% | -$6.11K | 0.01% | 229 |
|
|
2020
Q2 | $62K | Hold |
102,760
| – | – | ﹤0.01% | 217 |
|
|
2020
Q1 | $50K | Hold |
102,760
| – | – | ﹤0.01% | 217 |
|
|
2019
Q4 | $65K | Hold |
102,760
| – | – | ﹤0.01% | 249 |
|
|
2019
Q3 | $100K | Hold |
102,760
| – | – | 0.01% | 239 |
|
|
2019
Q2 | $169K | Hold |
102,760
| – | – | 0.01% | 221 |
|
|
2019
Q1 | $214K | Buy |
102,760
+9,585
| +10% | +$20K | 0.01% | 196 |
|
|
2018
Q4 | $26K | Buy |
+93,175
| New | +$26K | ﹤0.01% | 206 |
|